Mutations associated with age-related clonal hematopoiesis in PMF patients with rapid progression to myelofibrosis-Reference-Cited by-同舟云学术

Mutations associated with age-related clonal hematopoiesis in PMF patients with rapid progression to myelofibrosis

Published:2019-11-27 Issue:5 Volume:34 Page:1364-1372
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Bartels Stephan^ORCID,Faisal Muhammad,Büsche Guntram,Schlue Jerome,Hasemeier Britta,Schipper Elisa,Vogtmann Julia,Westphal Lina,Lehmann Ulrich,Kreipe Hans

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/s41375-019-0668-5.pdf

Reference26 articles.

1. Arber D, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, et al. The 2016 revision of the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127:2391–405.

2. Czader M, Orazi A. Acute myeloid leukemia and other types of disease progression in myeloproliferative neoplasms. Am J Clin Pathol. 2015;144:188–206.

3. Latagliata R, Polverelli N, Tieghi A, Palumbo GA, Breccia M, Sabattini E, et al. Comparison of JAK2V617F -positive essential thrombocythaemia and early primary myelofibrosis: the impact of mutation burden and histology. Hematol Oncol. 2018;36:269–75.

4. Hernández-Boluda JC, Pereira A, Correa JG, Alvarez-Larrán A, Ferrer-Marín F, Raja JM, et al. Prognostic risk models for transplant decision-making in myelofibrosis. Ann Hematol. 2018;97:813–20.

5. Tefferi A, Guglielmelli P, Nicolosi M, Mannelli F, Mudireddy M, Bartalucci N, et al. GIPSS: genetically inspired prognostic scoring system for primary myelofibrosis. Leukemia. 2018;32:1631–42.

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SOHO State of the Art Updates and Next Questions | Diagnosis, Outcomes, and Management of Prefibrotic Myelofibrosis;Clinical Lymphoma Myeloma and Leukemia;2024-07

2. Cytogenetics and genomics in CML and other myeloproliferative neoplasms;Best Practice & Research Clinical Haematology;2024-06

3. Evaluation of Absolute Neutrophil, Lymphocyte and Platelet Count and Their Ratios as Predictors of Thrombotic Risk in Patients with Prefibrotic and Overt Myelofibrosis;Life;2024-04-17

4. Molecular markers as possible efficacy predictors of targeted therapy for myelofibrosis: single-center study;Oncohematology;2023-12-08

5. Logical modelling of myelofibrotic microenvironment predicts dysregulated progenitor stem cell crosstalk;Biosystems;2023-09